Home/Pipeline/Proclaim XR SCS

Proclaim XR SCS

Chronic Pain Management

Marketed (Global)Commercialization in IndiaN/A

Key Facts

Indication

Chronic Pain Management

Phase

Marketed (Global)

Status

Commercialization in India

Company

Abbott India

About Abbott India

Abbott India's mission is to create new healthcare solutions that help people live their best lives, leveraging its parent company's global R&D while adapting to India's unique needs. The company has achieved a dominant market position with a valuation exceeding $550 billion, reflecting its extensive portfolio and deep market penetration. Its strategy centers on leveraging Abbott's global innovation pipeline, local manufacturing in Goa, and a multi-divisional approach to capture growth across India's expanding healthcare sectors.

View full company profile

Therapeutic Areas

Cardiovascular & Metabolic Diseases Diabetes Gastrointestinal Women's Health Infectious Diseases Neurology & Pain Nutrition

Other Chronic Pain Management Drugs

Drug	Company	Phase	Status
BioWaveHOME	BioWave	Commercial	Active
Cutaneous Field Stimulation (CFS) Device	Meagan Medical	Pre-clinical/Clinical Research	Active